Company research / BCRX
BIOCRYST PHARMACEUTICALS INC (BCRX)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, BIOCRYST PHARMACEUTICALS INC reported revenue of $874.84M. Revenue grew 94.1% from the prior annual period.
Key ratios (year ended 2025-12-31)
39.0%
Operating margin
30.2%
Net margin
94.1%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.